Home
Welcome to the CERMN website
With its four platforms and considerable analytical capacity, CERMN is recognized as an interdisciplinary drug design unit at the interface between the physicochemical and the biological sciences. CERMN has the expertise to design and produce novel derivatives with therapeutic or diagnostic interest. Compounds whose in vitro activity and drugability have been attested are then engaged in preclinical trials in association with biologists and pharmacologists. CERMN’s experience in this field contributed also to the creation in 2012 of a Master’s degree in Drug Design.
The areas of research currently being developed at the Centre are in cancer research and the neurosciences, with scientific priority given to polypharmacology and protein-protein interactions.... Read next page
The areas of research currently being developed at the Centre are in cancer research and the neurosciences, with scientific priority given to polypharmacology and protein-protein interactions.... Read next page
News
52nd edition of the International Conference on Medicinal Chemistry (RICT 2016) July 6, 2016 - July 8, 2016
Video presentation of the CERMN
Last update : September 14, 2016
CONTACT US
UNICAEN EA 4258
FR CNRS 3038 INC3M
SF 4206 ICORE
Boulevard Becquerel
14032 Caen Cedex, France
Tél : +33 (0)2 31 56 59 10
Fax : +33 (0)2 31 56 68 03
Dir : Pr Patrick DALLEMAGNE
patrick.dallemagne@unicaen.fr
Université de Caen Normandie
CERMN · Centre d’études et de recherche sur le médicament de Normandie
Boulevard Becquerel | 14032 Caen Cedex | France
CERMN · Centre d’études et de recherche sur le médicament de Normandie
Boulevard Becquerel | 14032 Caen Cedex | France
